Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Filings indexed 916 across all filing types
Latest filing 2022-04-07 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 95% confidence The document is very short (291 characters) and contains a tabular disclosure under Regulation 31(4) related to annual declaration of shareholding or promoter group information for a financial year ending 31-Mar-2022. It does not contain financial statements, management discussion, or detailed report content. It is a regulatory disclosure about shareholding or promoter group information, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-04-07 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is very short (291 characters) and appears to be a regulatory disclosure under Regulation 31(4), which relates to shareholding or promoter disclosures. It lists company and entity names, category, and financial year end but contains no financial statements or detailed report content. This fits the description of a Major Shareholding Notification rather than a full report or announcement of a report. Therefore, the appropriate classification is MRQ (Major Shareholding Notification).
2022-04-07 English
Pursuant to the SEBI Circular No.: SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, regarding Fund Raising by Issuance of Debt Securities by Large Entities; this is to confirm that ....
Regulatory Filings
2022-04-05 English
Annual Disclosure
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 171 characters, indicating it is extremely short and does not contain any report content. There is no indication of any report, announcement, or regulatory filing content. Given the lack of content, the document best fits the fallback category for miscellaneous filings that do not fit other categories, which is Regulatory Filings (RNS).
2022-04-05 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 113 characters, indicating it is extremely short and does not contain any report content. There is no indication of any report, announcement, or filing type. Given the lack of content, the document best fits the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2022-03-31 English
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform that the Trading Window for dealing in securities of Wanbury Limited (the 'Company') shall remain ....
Regulatory Filings
2022-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.